A prospective study of ketamine versus haloperidol for severe prehospital agitation
- PMID: 27102743
- DOI: 10.1080/15563650.2016.1177652
A prospective study of ketamine versus haloperidol for severe prehospital agitation
Abstract
Context: Ketamine is an emerging drug for the treatment of acute undifferentiated agitation in the prehospital environment, however no prospective comparative studies have evaluated its effectiveness or safety in this clinical setting.
Objective: We hypothesized 5 mg/kg of intramuscular ketamine would be superior to 10 mg of intramuscular haloperidol for severe prehospital agitation, with time to adequate sedation as the primary outcome measure.
Methods: This was a prospective open label study of all patients in an urban EMS system requiring chemical sedation for severe acute undifferentiated agitation that were subsequently transported to the EMS system's primary Emergency Department. All paramedics were trained in the Altered Mental Status Scale and prospectively recorded agitation scores on all patients. Two 6-month periods where either ketamine or haloperidol was the first-line therapy for severe agitation were prospectively compared primarily for time to adequate sedation. Secondary outcomes included laboratory data and adverse medication events.
Results: 146 subjects were enrolled; 64 received ketamine, 82 received haloperidol. Median time to adequate sedation for the ketamine group was 5 minutes (range 0.4-23) vs. 17 minutes (range 2-84) in the haloperidol group (difference 12 minutes, 95% CI 9-15). Complications occurred in 49% (27/55) of patients receiving ketamine vs. 5% (4/82) in the haloperidol group. Complications specific to the ketamine group included hypersalivation (21/56, 38%), emergence reaction (5/52, 10%), vomiting (5/57, 9%), and laryngospasm (3/55, 5%). Intubation was also significantly higher in the ketamine group; 39% of patients receiving ketamine were intubated vs. 4% of patients receiving haloperidol.
Conclusions: Ketamine is superior to haloperidol in terms of time to adequate sedation for severe prehospital acute undifferentiated agitation, but is associated with more complications and a higher intubation rate.
Keywords: Agitation; EMS; haloperidol; ketamine.
Comment in
-
Ketamine for agitation: a key cog in the prehospital treatment armamentarium wheelhouse.Clin Toxicol (Phila). 2016 Aug;54(7):545-6. doi: 10.1080/15563650.2016.1180391. Epub 2016 May 10. Clin Toxicol (Phila). 2016. PMID: 27163703 No abstract available.
Similar articles
-
Prehospital Agitation and Sedation Trial (PhAST): A Randomized Control Trial of Intramuscular Haloperidol versus Intramuscular Midazolam for the Sedation of the Agitated or Violent Patient in the Prehospital Environment.Prehosp Disaster Med. 2015 Oct;30(5):491-5. doi: 10.1017/S1049023X15004999. Epub 2015 Sep 1. Prehosp Disaster Med. 2015. PMID: 26323511 Clinical Trial.
-
A prospective study of ketamine as primary therapy for prehospital profound agitation.Am J Emerg Med. 2018 May;36(5):789-796. doi: 10.1016/j.ajem.2017.10.022. Epub 2017 Oct 7. Am J Emerg Med. 2018. PMID: 29033344
-
Rapid Agitation Control With Ketamine in the Emergency Department: A Blinded, Randomized Controlled Trial.Ann Emerg Med. 2021 Dec;78(6):788-795. doi: 10.1016/j.annemergmed.2021.05.023. Epub 2021 Aug 2. Ann Emerg Med. 2021. PMID: 34353650 Clinical Trial.
-
Ketamine for Rapid Sedation of Agitated Patients in the Prehospital and Emergency Department Settings: A Systematic Review and Proportional Meta-Analysis.J Emerg Med. 2018 Nov;55(5):670-681. doi: 10.1016/j.jemermed.2018.07.017. Epub 2018 Sep 7. J Emerg Med. 2018. PMID: 30197153
-
Ketamine for the Acute Management of Excited Delirium and Agitation in the Prehospital Setting.Pharmacotherapy. 2018 Jan;38(1):139-151. doi: 10.1002/phar.2060. Epub 2017 Dec 22. Pharmacotherapy. 2018. PMID: 29136301 Review.
Cited by
-
Rapid agitation control with ketamine in the emergency department (RACKED): a randomized controlled trial protocol.Trials. 2018 Nov 26;19(1):651. doi: 10.1186/s13063-018-2992-x. Trials. 2018. PMID: 30477544 Free PMC article.
-
Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression.Front Behav Neurosci. 2022 Jun 21;16:938044. doi: 10.3389/fnbeh.2022.938044. eCollection 2022. Front Behav Neurosci. 2022. PMID: 35801096 Free PMC article.
-
Haloperidol-Midazolam vs. Haloperidol-Ketamine in Controlling the Agitation of Delirious Patients; a Randomized Clinical Trial.Arch Acad Emerg Med. 2023 Aug 26;11(1):e61. doi: 10.22037/aaem.v11i1.2095. eCollection 2023. Arch Acad Emerg Med. 2023. PMID: 37840867 Free PMC article.
-
Outcomes Associated with Lower Doses of Ketamine by Emergency Medical Services for Profound Agitation.West J Emerg Med. 2021 Aug 30;22(5):1183-1189. doi: 10.5811/westjem.2021.5.50845. West J Emerg Med. 2021. PMID: 34546896 Free PMC article.
-
A Comparative Analysis Between Ketamine Versus Combination of Midazolam and Haloperidol for Rapid Safe Control of Agitated Patients in Emergency Department: A Systematic Review.Cureus. 2022 Jun 21;14(6):e26162. doi: 10.7759/cureus.26162. eCollection 2022 Jun. Cureus. 2022. PMID: 35891834 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical